336 related articles for article (PubMed ID: 31140779)
1. Small Molecule Inhibits Metal-Dependent and -Independent Multifaceted Toxicity of Alzheimer's Disease.
Samanta S; Rajasekhar K; Babagond V; Govindaraju T
ACS Chem Neurosci; 2019 Aug; 10(8):3611-3621. PubMed ID: 31140779
[TBL] [Abstract][Full Text] [Related]
2. Hybrid Multifunctional Modulators Inhibit Multifaceted Aβ Toxicity and Prevent Mitochondrial Damage.
Rajasekhar K; Mehta K; Govindaraju T
ACS Chem Neurosci; 2018 Jun; 9(6):1432-1440. PubMed ID: 29557650
[TBL] [Abstract][Full Text] [Related]
3. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
4. Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-β Aggregation, Oxidative Stress, and Inflammation in Alzheimer's Disease.
Nam E; Derrick JS; Lee S; Kang J; Han J; Lee SJC; Chung SW; Lim MH
ACS Chem Neurosci; 2018 Nov; 9(11):2655-2666. PubMed ID: 29782798
[TBL] [Abstract][Full Text] [Related]
5. Natural Tripeptide-Based Inhibitor of Multifaceted Amyloid β Toxicity.
Rajasekhar K; Madhu C; Govindaraju T
ACS Chem Neurosci; 2016 Sep; 7(9):1300-10. PubMed ID: 27355515
[TBL] [Abstract][Full Text] [Related]
6. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
Smith DG; Cappai R; Barnham KJ
Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
[TBL] [Abstract][Full Text] [Related]
7. Copper and heme-mediated Abeta toxicity: redox chemistry, Abeta oxidations and anti-ROS compounds.
Chassaing S; Collin F; Dorlet P; Gout J; Hureau C; Faller P
Curr Top Med Chem; 2012; 12(22):2573-95. PubMed ID: 23339309
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.
Han J; Du Z; Lim MH
Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227
[TBL] [Abstract][Full Text] [Related]
9. Importance of the Dimethylamino Functionality on a Multifunctional Framework for Regulating Metals, Amyloid-β, and Oxidative Stress in Alzheimer's Disease.
Derrick JS; Kerr RA; Korshavn KJ; McLane MJ; Kang J; Nam E; Ramamoorthy A; Ruotolo BT; Lim MH
Inorg Chem; 2016 May; 55(10):5000-13. PubMed ID: 27119456
[TBL] [Abstract][Full Text] [Related]
10. Redox-active metals, oxidative stress, and Alzheimer's disease pathology.
Huang X; Moir RD; Tanzi RE; Bush AI; Rogers JT
Ann N Y Acad Sci; 2004 Mar; 1012():153-63. PubMed ID: 15105262
[TBL] [Abstract][Full Text] [Related]
11. Management of oxidative stress and other pathologies in Alzheimer's disease.
Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
[TBL] [Abstract][Full Text] [Related]
12. Rationally Designed Molecules Synergistically Modulate Multifaceted Aβ Toxicity, Microglial Activation, and Neuroinflammation.
Ramesh M; Balachandra C; Andhare P; Govindaraju T
ACS Chem Neurosci; 2022 Jul; 13(14):2209-2221. PubMed ID: 35759686
[TBL] [Abstract][Full Text] [Related]
13. Triazole-Peptide Conjugate as a Modulator of Aβ-Aggregation, Metal-Mediated Aβ-Aggregation, and Cytotoxicity.
Mann S; Kaur A; Kaur A; Priyadarshi N; Goyal B; Singhal NK; Goyal D
ACS Chem Neurosci; 2023 May; 14(9):1631-1645. PubMed ID: 37040092
[TBL] [Abstract][Full Text] [Related]
14. Effects of multifunctional antioxidants on mitochondrial dysfunction and amyloid-β metal dyshomeostasis.
Kawada H; Blessing K; Kiyota T; Woolman T; Winchester L; Kador PF
J Alzheimers Dis; 2015; 44(1):297-307. PubMed ID: 25227315
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta.
Atwood CS; Obrenovich ME; Liu T; Chan H; Perry G; Smith MA; Martins RN
Brain Res Brain Res Rev; 2003 Sep; 43(1):1-16. PubMed ID: 14499458
[TBL] [Abstract][Full Text] [Related]
16. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
Drew SC; Barnham KJ
Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
[TBL] [Abstract][Full Text] [Related]
17. Rodent Abeta(1-42) exhibits oxidative stress properties similar to those of human Abeta(1-42): Implications for proposed mechanisms of toxicity.
Boyd-Kimball D; Sultana R; Mohmmad-Abdul H; Butterfield DA
J Alzheimers Dis; 2004 Oct; 6(5):515-25. PubMed ID: 15505374
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress and the amyloid beta peptide in Alzheimer's disease.
Cheignon C; Tomas M; Bonnefont-Rousselot D; Faller P; Hureau C; Collin F
Redox Biol; 2018 Apr; 14():450-464. PubMed ID: 29080524
[TBL] [Abstract][Full Text] [Related]
19. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
Butterfield DA
Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
[TBL] [Abstract][Full Text] [Related]
20. Rutin inhibits β-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines.
Wang SW; Wang YJ; Su YJ; Zhou WW; Yang SG; Zhang R; Zhao M; Li YN; Zhang ZP; Zhan DW; Liu RT
Neurotoxicology; 2012 Jun; 33(3):482-90. PubMed ID: 22445961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
